This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Centrillion Technology Holdings Corporation. Active years: 2021-2022.
Company Filing History:
Years Active: 2021-2022
I specialize in innovations, inventions, inventors, patent attorneys, assignees, and patents.
Title: Inventor Spotlight: Kendall Hoff
Introduction:
Kendall Hoff, a prolific inventor based in San Francisco, CA, has made significant contributions to the field of enzymatic synthesis of oligonucleotides. With a total of 2 patents to his name, Hoff's innovative work has been instrumental in advancing biotechnology.
Latest Patents:
1. Method and System for Enzymatic Synthesis of Oligonucleotides: Hoff's groundbreaking patent focuses on enzymatically synthesizing single-stranded oligonucleotides from an immobilized primer using a polymerase. This method allows for the synthesis of oligonucleotides in the presence of deoxyribonucleotide triphosphates or ribonucleotide triphosphates.
2. Disulfide-Linked Reversible Terminators: Another cutting-edge patent by Hoff involves sequencing polynucleotides using compounds with a unique sugar moiety and base structure. These compounds contain a cleavable chemical group capping the 3'-OH group and a base linked to a label through a disulfide bond cleavable by a chemical reagent.
Career Highlights:
Hoff is affiliated with Centrillion Technology Holdings Corporation, a prominent company in the biotechnology sector. His work at Centrillion has been pivotal in developing innovative technologies for genomic research and sequencing.
Collaborations:
Hoff's collaborative efforts with coworkers Wei Zhou and Michelle Halpain have led to the successful implementation of his patented technologies in real-world applications. Together, they have pushed the boundaries of biotechnology and molecular biology.
Conclusion:
Kendall Hoff's inventive spirit and dedication to advancing enzymatic synthesis and sequencing technologies have cemented his reputation as a trailblazer in the field of biotechnology. His patents stand as a testament to his expertise and commitment to driving innovation forward.
